Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
Erlotinib can prolong survival in patients with non-small-cell lung cancer after first-line or second-line chemotherapy.
Erlotinib can prolong survival in patients with non-small-cell lung cancer after first-line or second-line chemotherapy.